Evidence map›Paper›PMID 23535233›Full record

ArticleActa biomaterialia2013

Acoustic droplet-hydrogel composites for spatial and temporal control of growth factor delivery and scaffold stiffness.

Mario L Fabiilli, Christopher G Wilson, Frédéric Padilla, Francisco M Martín-Saavedra, J Brian Fowlkes, Renny T Franceschi

Abstract read
In one paragraph

Article in Acta biomaterialia, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 49 papers.

0numbers the graph read from it
0cells of the map it votes in
49citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

49 citing papers in PubMed.

  1. Article
  2. Article
  3. Review
  4. Unlocking Transplant Tolerance with Biomaterials.Advanced healthcare materials · 2025
    Review
  5. Article
  6. Acoustically responsive scaffolds: Unraveling release kinetics and mechanisms for sustained, steady drug delivery.Journal of controlled release : official journal of the Controlled Release Society · 2024
    Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Review
  17. Article
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Mario L FabiilliDepartment of Radiology, University of Michigan Health System, Ann Arbor, MI, USA. mfabiill@umich.edu
Christopher G Wilson
Frédéric Padilla
Francisco M Martín-Saavedra
J Brian Fowlkes
Renny T Franceschi

Funding

Tissue Engineering and RegenerationT32DE007057 · NIDCR · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI DAVID H. KOHN · 1985 to 2026
$17.3M
GENE THERAPY APPROACH FOR ENGINEERING CRANIOFACIAL BONER01DE013386 · NIDCR · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI FRANCESCHI, RENNY THEODORE · 2000 to 2011
$2.8M
Multipotent lung mesenchymal cells in neonatal lung injuryR01HL090134 · NHLBI · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI HERSHENSON, MARC B. · 2007 to 2010
$1.5M
NHLBI NIH HHS R01 HL090134NIDCR NIH HHS R01 DE013386NIDCR NIH HHS R01DE013386-09NIDCR NIH HHS T32 DE007057NIDCR NIH HHS T32DE007057-34
6 · The paper itself

Abstract

Wound healing is regulated by temporally and spatially restricted patterns of growth factor signaling, but there are few delivery vehicles capable of the "on-demand" release necessary for recapitulating these patterns. Recently we described a perfluorocarbon double emulsion that selectively releases a protein payload upon exposure to ultrasound through a process known as acoustic droplet vaporization (ADV). In this study, we describe a delivery system composed of fibrin hydrogels doped with growth factor-loaded double emulsion for applications in tissue regeneration. Release of immunoreactive basic fibroblast growth factor (bFGF) from the composites increased up to 5-fold following ADV and delayed release was achieved by delaying exposure to ultrasound. Releasates of ultrasound-treated materials significantly increased the proliferation of endothelial cells compared to sham controls, indicating that the released bFGF was bioactive. ADV also triggered changes in the ultrastructure and mechanical properties of the fibrin as bubble formation and consolidation of the fibrin in ultrasound-treated composites were accompanied by up to a 22-fold increase in shear stiffness. ADV did not reduce the viability of cells suspended in composite scaffolds. These results demonstrate that an acoustic droplet-hydrogel composite could have broad utility in promoting wound healing through on-demand control of growth factor release and/or scaffold architecture.

Indexed as

Tissue ScaffoldsDelayed-Action PreparationsDiffusionDrug ImplantsElastic ModulusEquipment DesignEquipment Failure AnalysisFibroblast Growth Factor 2HydrogelsIntercellular Signaling Peptides and ProteinsMaterials TestingSonicationSoundSpatio-Temporal AnalysisDelayed-Action PreparationsDrug ImplantsFibroblast Growth Factor 2HydrogelsIntercellular Signaling Peptides and Proteins

Identifiers

PMID23535233
PMCPMC3746980

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.